Ionis Angioedema Drug Shows Positive Results in Phase 3 Trial (NASDAQ:IONS)
Ionis Pharmaceuticals (NASDAQ:IONS) on Monday announced positive results from the Phase 3 trial of its drug candidate donidalorsen for hereditary ...
Ionis Pharmaceuticals (NASDAQ:IONS) on Monday announced positive results from the Phase 3 trial of its drug candidate donidalorsen for hereditary ...